Management of Fanconi Syndrome
The cornerstone of Fanconi syndrome management is aggressive fluid and electrolyte replacement combined with treatment of the underlying cause when identifiable, with specific disease-directed therapies for inherited forms like cystinosis requiring immediate cysteamine initiation. 1
Immediate Supportive Care
Fluid and Electrolyte Replacement
- Administer intravenous 10% dextrose/normal saline solutions at 1.5-2.0 times maintenance rate to maintain normoglycemia and prevent dehydration from sodium wasting. 1
- Provide phosphate supplementation to address hypophosphatemia and prevent progressive bone disease (rickets in children, osteomalacia in adults). 2
- Correct hypokalemia with potassium supplementation, which is often severe due to urinary losses exacerbated by metabolic acidosis. 2
- Administer bicarbonate supplementation to correct the type II renal tubular acidosis that characterizes this condition. 2
Disease-Specific Management
Cystinosis-Related Fanconi Syndrome
- Initiate cysteamine therapy immediately upon diagnosis confirmation at 1 mg/kg/day, escalating to 2 mg/kg/day if no improvement is observed. 1
- Implement nutritional management with restriction of phenylalanine and tyrosine intake, use medical foods devoid of these amino acids, and ensure protein intake higher than normal requirements. 1
Tyrosinemia Type I-Associated Fanconi Syndrome
- Start NTBC (nitisinone) treatment with dietary restriction of phenylalanine/tyrosine, which reverses or prevents tubulopathy in nearly all cases within weeks. 1
- Continue periodic screening for renal disease even after liver transplantation, as succinylacetone excretion persists post-transplant. 1
Acquired Forms (Adults)
- Conduct comprehensive medication and toxin review, as drugs, exogenous toxins, and heavy metals are the main causes in adults. 2, 3
- Discontinue offending agents immediately (including dietary supplements like red yeast rice, which can cause Fanconi syndrome). 4
- Perform serum and urine protein electrophoresis to screen for multiple myeloma with light chain deposition, the most common acquired cause in adults. 2
Fanconi Anemia-Related Manifestations
Hematologic Monitoring
- Obtain complete blood count at diagnosis with frequent ongoing monitoring. 1
- Perform bone marrow aspirate and biopsy at diagnosis and annually thereafter. 1
Cancer Surveillance
- Implement monthly oral self-examinations starting in early adolescence. 1
- Schedule biannual dental examinations. 1
- Arrange annual head and neck squamous cell carcinoma evaluation by otolaryngologist beginning in early adolescence. 1
- Conduct annual gynecologic examination starting in adolescence. 1
- Administer HPV vaccination per standard schedule. 1
Treatment of Bone Marrow Failure
- Consider androgen therapy, lower-dose hematopoietic stem cell transplantation regimens, and avoid DNA-damaging agents. 1
Ongoing Monitoring and Follow-up
Laboratory Assessment
- Regularly assess renal function through blood and urine tests including electrolytes, glucose, amino acids, and phosphate. 1
- Monitor serum creatinine and eGFR to track kidney function decline. 2
- Quantify proteinuria through albumin:creatinine ratio and protein:creatinine ratio. 2
- Check alkaline phosphatase levels, which are often elevated in rickets/osteomalacia from chronic phosphate wasting. 2
Imaging Studies
- Perform renal ultrasound to monitor kidney structure. 1
- Obtain bone X-rays and densitometry to assess for rachitic changes from hypophosphatemia. 1
Kidney Biopsy Indications
Perform kidney biopsy when Fanconi syndrome presents with hypouricemia, eGFR <60 mL/min/1.73m² with >2 mL/min/1.73m² per year decline, proteinuria with hematuria, or albumin:creatinine ratio >30 mg/mmol. 2
Genetic Testing
- Order genetic testing for inherited causes including cystinosis (CTNS gene), tyrosinemia type I, Fanconi anemia (multiple genes), and glycogen storage diseases when clinical presentation suggests hereditary etiology. 2
Critical Pitfalls to Avoid
- Do not overlook dietary supplements and non-prescription substances during history-taking, as these are increasingly recognized causes of acquired Fanconi syndrome. 4
- Do not delay cysteamine therapy in suspected cystinosis cases, as early treatment prevents irreversible complications. 1
- Do not assume liver transplantation cures tyrosinemia-related renal disease; continued monitoring is essential. 1